Research suggests it may assist in mitigating the effects of physical strain and support the body's natural wellness processes
Who's eligible The program isn't open to everyone on Medicare
CrossRef Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim Diabetes & Metabolism Journal.2017
For a detailed comparison of dosing between the two medications, see our semaglutide versus tirzepatide comparison
White is averaging 13.8 points and 6.7 rebounds per contest
Mounjaro and Ozempic are FDA-approved for treating type 2 diabetes but may be prescribed off-label for weight loss at a healthcare providers discretion